Prostate-specific antigen (PSA) and the related kallikrein family of serine proteases are current or emerging biomarkers for prostate cancer detection and progression. Kallikrein 4 (KLK4/hK4) is of particular interest, as KLK4 mRNA has been shown to be elevated in prostate cancer. In this study, we now show that the comparative expression of hK4 protein in prostate cancer tissues, compared with benign glands, is greater than that of PSA and kallikrein 2 (KLK2/hK2), suggesting that hK4 may play an important functional role in prostate cancer progression in addition to its biomarker potential. To examine the roles that hK4, as well as PSA and hK2, play in processes associated with progression, these kallikreins were separately transfected int...
The reciprocal communication between cancer cells and their microenvironment is critical in cancer p...
Prostate cancer is a leading cause of male cancer-related death and novel therapies are required tha...
Prostate cancer metastasis to bone is terminal; thus, novel therapies are required to prevent end-st...
Prostate-specific antigen (PSA) and the related kallikrein family of serine proteases are current or...
Several members of the kallikrein-related peptidase family of serine proteases have proteolytic acti...
At present, prostate cancer is a significant public health issue throughout the world and is the sec...
The prostate-specific antigen-related serine protease gene, kallikrein 4 (KLK4), is expressed in the...
BACKGROUND: Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. K...
BACKGROUND. Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. K...
The human kallikrein (hk) family, located on chromosome 19, encodes prostate-specific antigen (PSA [...
The human kallikrein (hk) family, located on chromosome 19, encodes prostate-specific antigen (PSA [...
The introduction of testing for prostate-specific antigen (PSA), a member of the fifteen-gene family...
Kallikreins are a family of serine proteases with a range of tissue-specific and essential proteolyt...
A major characteristic of prostate cancer is the elevation of serum levels of prostate-specific anti...
The reciprocal communication between cancer cells and their microenvironment is critical in cancer p...
The reciprocal communication between cancer cells and their microenvironment is critical in cancer p...
Prostate cancer is a leading cause of male cancer-related death and novel therapies are required tha...
Prostate cancer metastasis to bone is terminal; thus, novel therapies are required to prevent end-st...
Prostate-specific antigen (PSA) and the related kallikrein family of serine proteases are current or...
Several members of the kallikrein-related peptidase family of serine proteases have proteolytic acti...
At present, prostate cancer is a significant public health issue throughout the world and is the sec...
The prostate-specific antigen-related serine protease gene, kallikrein 4 (KLK4), is expressed in the...
BACKGROUND: Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. K...
BACKGROUND. Prostate cancer (PCa) and bone cell interactions are critical in the metastatic phase. K...
The human kallikrein (hk) family, located on chromosome 19, encodes prostate-specific antigen (PSA [...
The human kallikrein (hk) family, located on chromosome 19, encodes prostate-specific antigen (PSA [...
The introduction of testing for prostate-specific antigen (PSA), a member of the fifteen-gene family...
Kallikreins are a family of serine proteases with a range of tissue-specific and essential proteolyt...
A major characteristic of prostate cancer is the elevation of serum levels of prostate-specific anti...
The reciprocal communication between cancer cells and their microenvironment is critical in cancer p...
The reciprocal communication between cancer cells and their microenvironment is critical in cancer p...
Prostate cancer is a leading cause of male cancer-related death and novel therapies are required tha...
Prostate cancer metastasis to bone is terminal; thus, novel therapies are required to prevent end-st...